Antitrypanosomal activity of purine nucleosides can be enhanced by their conversion to O-acetylated derivatives

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 11, 1996, Pages 2567-2572

  Sufrin, Janice R ^a   Rattendi, Donna ^b   Spiess, Arthur J ^a   Lane, Schennella ^b   Marasco Jr , Canio J ^a   Bacchi, Cyrus J ^b  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b PACE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PURINE NUCLEOSIDE;

ANTIPROTOZOAL ACTIVITY; ARTICLE; DRUG ACETYLATION; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; TRYPANOSOMIASIS;

EID: 0029861736     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.11.2567     Document Type: Article

References (29)

1. Bacchi, C. J., J. Garofalo, M. A. Ciminelli, D. Rattendi, B. Goldberg, P. P. McCann, and N. Yarlett. 1993. Resistance to DL-α-difluoromethylornithine by clinical isolales of Trypanosoma brucei rhodesiense: role of S-adenosylmethionine. Biochem. Pharmacol. 46:471-481.
2. Bacchi, C. J., and P. P. McCann. 1987. Parasitic protozoa and polyamines, p. 317-344. In P. P. McCann, A. E. Pegg, and A. Sjoerdsma (ed.), Inhibition of polyamine metabolism: biological significance and basis for new therapies. Academic Press, New York.
3. Bacchi, C. J., and J. R. Sufrin. Unpublished data.
4. Bacchi, C. J., J. R. Sufrin, H. C. Nathan, A. J. Spiess, T. Hannan, J. Garofalo, K. Alecia, L. Katz, and N. Yarlett. 1991. 5′-Alkyl-substituted analogs of 5′-methylthioadenosine as trypanocides. Antimicrob. Agents Chemother. 35:1315-1320.
5. Berens, R. L., E. C. Krug, and J. J. Marr. 1995. Purine and pyrimidine metabolism, p. 89-116. In J. J. Marr and M. Muller (ed.), Biochemistry and molecular biology of parasites. Academic Press, New York.
6. Berger, B. J., N. S. Carter, and A. J. Fairlamb. 1995. Characterization of pentamidine-resistant Trypanosoma brucei brucei. Mol. Biochem. Parasitol. 69:289-298.
7. Bitonti, A. J., T. L. Byers, T. L. Bush, P. J. Casara, C. J. Bacchi, A. B. Clarkson, Jr., P. P. McCann, and A. Sjoerdsma. 1990. Cure of Trypanosoma brucei brucei and Trypanosoma brucei rhodesiense infections in mice with an irreversible inhibitor of S-adenosylmethionine. Antimicrob. Agents Chemother. 34:1485-1490.
8. Borchardt, R. T. 1979. Mechanism of alkaline hydrolysis of S-adenosyl-L-methionine and related sulfonium nucleosides. J. Am. Chem. Soc. 101:458-463.
9. Byers, T. L., P. Casara, and A. J. Bitonti. 1992. Uptake of the antitrypanosomal drug 5′-{[(Z)-4-amino-2-butenyl]methylamino}-5′-deoxyadenosine (MDL73811) by the purine transport system of Trypanosoma brucei brucei. Biochem. J. 283:755-758.
10. 2 nucleoside transporter in melarsen-sensitive and -resistant Trypanosoma brucei brucei. J. Biol. Chem. 270:28153-28157.
11. Carter, N. S., and A. H. Fairlamb. 1993. Arsenical-resistant trypanosomes lack an unusual adenosine transporter. Nature (London) 361:173-176.
12. Casara, P., P. Marchal, J. Wagner, and C. Danzin. 1989. 5′{[(Z)-4-amino-2-butenyl]methylamino}-5′-deoxyadenosine: a potent enzyme-activated irreversible inhibitor of S-adenosyl-L-methionine decarboxylase from Escherichia coli. J. Am. Chem. Soc. 111:9111-9113.
13. Corey, E. J., and A. Venkateswarlu. 1972. Protection of hydroxyl groups as tert-butyldimethylsilyl derivatives. J. Am. Chem. Soc. 94:6190-6191.
14. Ferro, A. J., A. A. Vandenbark, and M. R. MacDonald. 1981. Inactivation of S-adenosylhomocysteine hydrolase by 5′-deoxy-5′-methylthioadenosine. Biochem. Biophys. Res. Commun. 100:523-531.
15. Goldberg, B., N. Yarlett, J. R. Sufrin, D. Lloyd, and C. J. Bacchi. Submitted for publication.
16. Hibasami, H., R. T. Borchardt, S. Y. Chen, J. K. Coward, and A. E. Pegg. 1980. Studies of inhibition of rat spermidine synthase and spermine synthase. Biochem. J. 187:419-428.
17. Hirumi, H., and K. Hirumi. 1989. Continuous cultivation of Trypanosoma brucei bloodstream forms in a medium containing a low concentration of serum protein without feeder cell layers. J. Parasitol. 75:985-989.
18. Kuzoe, F. 1993. Current situation of African trypanosomiasis. Acta Trop. 54:153-162.
19. Marr, J. J. 1991. Purine metabolism in parasitic protozoa and its relationship to chemotherapy, p. 524-536. In G. H. Coombs and M. J. North (ed.), Biochemical protozoology. Taylor & Francis, London.
20. Marton, L. J., and A. E. Pegg. 1995. Polyamines as targets for therapeutic intervention. Ann. Rev. Pharmacol. Toxicol. 35:55-91.
21. Montgomery, J. A., and K. Hewson. 1968. Analogs of 6-methyl-9-β-D-ribofuranosylpurine. J. Med. Chem. 11:48-52.
22. Pajula, R.-L., and A. Raina. 1979. Methylthioadenosine, a potent inhibitor of spermine synthase from bovine brain. FEBS Lett. 99:343-345.
23. Phelouzat, M. A., M. Basselin, F. Lawrence, and M. Robert-Gero. 1995. Sinefungin shares Ado-Met uptake system to enter Leishmania donovani. Biochem. J. 305:133-137.
24. Schechter, P. J., and A. Sjoerdsma. 1989. Therapeutic utility of selected enzyme-activated irreversible inhibitors, p. 201-210. In M. G. Palfreyman, P. P. McCann, W. Lovenberg, J. G. Temple, and A. Sjoerdsma (ed.), Enzymes as targets for drug design. Academic Press, New York.
25. Sufrin, J. R., A. J. Spiess, D. L. Kramer, P. L. Libby, J. T. Miller, R. J. Bernacki, R. T. Borchardt, Y. Lee, and C. W. Porter. 1991. Targeting 5′-deoxy-5′-(methylthio)adenosine phosphorylase by 5′-haloalkyl analogues of 5′-deoxy-5′-(methylthio)adenosine. J. Med. Chem. 34:2600-2606.
26. Sufrin, J. R., A. J. Spiess, C. J. Marasco, S. L. Croft, D. Snowdon, V. Yardley, and C. J. Bacchi. 1995. Purine 2′,3′-acyclonucleosides: improved synthesis and antiparasitic activity. Bioorg. Med. Chem. Lett. 5:1961-1964.
27. Trager, W. 1978. Cultivation of parasites in vitro. Am. J. Trop. Med. Hyg. 27:216-222.
28. Van Nieuwenhove, S. 1992. Advances in sleeping sickness therapy. Ann. Soc. Belge. Med. Trop. 72(Suppl. 1):39-51.
29. World Health Organization. 1995. Tropical disease research. Twelfth Programme Report. World Health Organization, Geneva.